Ocular therapeutix, inc. (OCUL)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Dec'13
Assets
Current assets:
Cash and cash equivalents

48,152

54,437

65,414

61,765

76,251

54,062

56,861

56,834

62,911

41,538

51,165

63,049

54,682

32,936

52,234

48,170

46,212

30,784

41,198

78,686

12,523

37,393

80,892

19,944

17,505

Marketable securities

-

-

-

-

-

-

-

-

-

-

-

3,000

25,697

35,209

23,513

35,717

49,244

74,280

72,445

45,036

54,900

37,435

-

-

0

Accounts receivable from related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

1

19

Accounts receivable, net

3,429

2,548

1,114

615

276

201

240

285

170

226

278

-

-

250

-

-

-

193

189

164

352

329

53

60

250

Accounts receivable

-

-

-

-

-

-

-

-

-

-

-

211

244

-

243

223

227

-

-

-

-

-

-

-

-

Inventory

1,107

954

895

762

265

217

102

131

139

122

127

90

96

113

126

149

127

134

147

145

158

133

117

109

-

Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,197

-

Prepaid expenses and other current assets

2,465

2,231

2,213

2,294

2,380

1,713

1,071

1,222

1,256

1,453

883

1,978

2,557

1,390

708

715

1,287

1,592

1,919

2,608

1,537

893

1,211

283

240

Total current assets

55,153

60,170

69,636

65,436

79,172

56,193

58,274

58,472

64,476

43,339

52,453

68,328

83,276

69,898

76,824

84,974

97,097

106,983

115,898

126,639

69,470

76,183

82,274

22,594

18,014

Property and equipment, net

9,473

10,151

10,474

10,532

10,548

10,236

10,382

10,373

10,595

10,478

10,218

9,619

5,693

3,313

3,795

3,199

3,107

3,095

3,193

2,603

1,799

1,782

1,376

1,152

904

Restricted cash

1,764

1,764

1,764

6,764

6,614

6,614

1,614

1,614

1,614

1,614

1,728

1,728

1,728

1,728

1,728

1,728

228

228

228

228

228

228

228

228

228

Operating lease assets

6,467

6,655

6,836

7,010

5,156

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total assets

72,857

78,740

88,710

89,742

101,490

73,043

70,270

70,459

76,685

55,431

64,399

79,675

90,697

74,939

82,347

89,901

100,432

110,306

119,319

129,470

71,497

78,193

83,878

23,974

19,146

Liabilities and Stockholders' Deficit
Current liabilities:
Accounts payable

2,839

3,268

3,461

4,044

3,902

2,965

2,777

2,137

3,477

3,571

2,599

6,307

3,754

2,116

1,680

1,611

2,063

1,957

1,624

2,812

2,195

1,316

649

1,525

545

Accrued expenses and other current liabilities

5,018

7,635

6,471

5,059

4,037

6,194

4,535

3,680

3,603

4,310

4,353

4,379

4,005

4,635

2,791

2,342

2,779

3,379

3,591

2,284

1,922

3,016

2,480

1,629

741

Operating lease liabilities

1,181

1,126

1,073

1,024

675

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

42

83

125

250

188

250

250

250

Notes payable, net of discount, current

2,074

-

-

-

-

-

6,094

6,082

6,071

5,545

3,993

2,444

897

1,549

3,772

2,466

1,161

-

5,883

4,370

2,860

1,354

-

1,085

1,806

Total current liabilities

11,112

12,029

11,005

10,127

8,614

9,159

13,406

11,899

13,151

13,426

10,945

13,130

8,656

8,300

8,243

6,419

6,003

5,378

11,181

9,591

7,227

5,874

3,379

4,489

3,342

Other liabilities

-

-

-

-

-

3,221

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities, net of current portion

8,590

8,905

9,206

9,493

7,909

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Derivative liability

15,528

12,124

9,100

13,068

11,462

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

852

254

Deferred rent, long-term

-

-

-

-

-

-

3,274

3,283

3,336

3,387

3,608

3,146

1,315

537

32

42

55

68

81

94

103

112

121

119

27

Notes payable, net of discount

22,987

25,007

24,952

24,898

24,843

24,788

8,073

9,548

11,014

12,471

13,924

15,374

16,821

14,094

11,778

12,992

14,204

15,272

9,249

10,673

12,094

13,511

14,776

13,594

651

2026 convertible notes, net

25,299

24,305

23,146

23,898

23,014

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

83,516

82,370

77,409

81,484

75,842

37,168

24,753

24,730

27,501

29,284

28,477

31,650

26,792

22,931

20,053

19,453

20,262

20,718

20,511

20,358

19,424

19,497

18,276

19,054

4,274

Commitments and contingencies (Note 12)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Redeemable convertible preferred stock (Series A, B, C, D and D-1), $0.001 par value; no shares and 33,979,025 shares authorized at December 31, 2014 and 2013, respectively; no shares and 32,842,187 shares issued and outstanding at December 31, 2014 and 2013, respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

74,344

Stockholders’ equity:
Preferred stock, $0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at March 31, 2020 and December 31, 2019, respectively

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

Common stock, $0.0001 par value; 100,000,000 shares authorized and 53,037,703 and 50,333,559 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

5

5

5

4

4

4

4

4

4

3

3

3

3

3

2

2

2

2

2

2

2

2

2

0

-

Additional paid-in capital

394,463

379,980

368,894

347,074

340,011

333,114

325,357

310,559

300,210

263,409

260,082

256,618

253,813

225,889

223,344

221,897

220,184

218,830

217,361

216,133

149,077

148,122

-

-

1,308

Additional paid-in capital

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

147,074

4,745

-

Accumulated deficit

-405,127

-383,615

-357,598

-338,820

-314,367

-297,243

-279,844

-264,834

-251,030

-237,265

-224,163

-208,596

-189,902

-173,879

-161,057

-151,461

-140,016

-129,176

-118,539

-107,015

-97,006

-89,428

-81,474

-74,180

-60,780

Accumulated other comprehensive loss

-

-

-

-

-

-

-

-

-

-

-

-

-9

-5

5

10

-

-68

-16

-8

-

-

-

-

-

Total stockholders’ deficit

-10,659

-3,630

11,301

8,258

25,648

35,875

45,517

45,729

49,184

26,147

35,922

48,025

63,905

52,008

62,294

70,448

80,170

89,588

98,808

109,112

52,073

58,696

65,602

-69,435

-59,472

Total liabilities and stockholders’ deficit

72,857

78,740

88,710

89,742

101,490

73,043

70,270

70,459

76,685

55,431

64,399

79,675

90,697

74,939

82,347

89,901

100,432

110,306

119,319

129,470

71,497

78,193

83,878

23,974

19,146